These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 21354480

  • 1. Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.
    Murata H, Macauley J, Lewis AM, Peden K.
    Vaccine; 2011 Apr 12; 29(17):3155-61. PubMed ID: 21354480
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K, Kumihashi H, Nerome R, Hiromoto Y, Yokota Y, Ueda R, Omoe K, Chiba M.
    Dev Biol Stand; 1999 Apr 12; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [Abstract] [Full Text] [Related]

  • 3. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D, Park KJ, Lee H, Cho EY, Kim MS, Hwang MH, Kim SI, Ahn DH.
    Virus Res; 2015 Jun 02; 204():40-6. PubMed ID: 25892718
    [Abstract] [Full Text] [Related]

  • 4. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, Youil R.
    Virus Res; 2004 Oct 02; 105(2):183-94. PubMed ID: 15351492
    [Abstract] [Full Text] [Related]

  • 5. Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds.
    Harada Y, Takahashi H, Trusheim H, Roth B, Mizuta K, Hirata-Saito A, Ogane T, Odagiri T, Tashiro M, Yamamoto N.
    Influenza Other Respir Viruses; 2020 Mar 02; 14(2):204-209. PubMed ID: 31651085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA, Kodihalli S, Alymova IV, Fanget B, Webster RG.
    Dev Biol Stand; 1999 Mar 02; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH, Seo SU, Song JM, Lee CM, Kim HA, Seong BL.
    Vaccine; 2006 Mar 10; 24(11):1966-74. PubMed ID: 16343703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.